AI Summary
This is a Request for Quotation (RFQ) from Rosalind Franklin University of Medicine and Science. It relates to a novel glioblastoma therapy developed by UP Oncolytics, a Helix 51 incubator company, which showed encouraging preclinical results. No specific requirements for the bid are mentioned in the provided text.